X4 Pharmaceuticals Announces $125 Million Capital Infusion from $105 Million Sale of Priority Review Voucher and $20 Million Drawdown from Existing Loan Facility
May 9, 2024
Acasti Announces Appointment of Prashant Kohli as CEO
April 4, 2023
Related Post
-
-
Alzamend Neuro Announces Agreement for Registered Direct Offering and Concurrent Private Placement for an Aggregate of up to $25 Million
May 9, 2024
-
Coeptis Therapeutics to Present its Universal Allogeneic SNAP-CAR NK Cell Therapy at the ISCT 2024
May 8, 2024
-
Lexaria Begins Dosing of Its Second GLP-1 Human Pilot Study
May 8, 2024